• Explore /
  • Poster
  • / Utility of surgically documented minimal residual disease as a therapeutic target and early surrogate of frontline treatment outcomes in ovarian cancer.

Utility of surgically documented minimal residual disease as a therapeutic target and early surrogate of frontline treatment outcomes in ovarian cancer.

Abstract Poster

Authors

null

Anne Knisely

University of Texas MD Anderson Cancer Center, Houston, TX

Anne Knisely , Roni Nitecki Wilke , Bryan M. Fellman , Jose Alejandro Rauh-Hain , Robert Tyler Hillman , Jolyn Sharpe Taylor , Lois M. Ramondetta , Michaela Onstad , Lauren Patterson Cobb , David M. Boruta , Gwyn Richardson , Pamela T. Soliman , Aaron Shafer , Shannon Neville Westin , Nicole D. Fleming , Travis T. Sims , Anil K Sood , Pedro T. Ramirez , Karen H. Lu , Amir A. Jazaeri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5549)

DOI

10.1200/JCO.2023.41.16_suppl.5549

Abstract #

5549

Poster Bd #

244

Abstract Disclosures

Similar Posters

First Author: Helene Blons

First Author: Travis T. Sims

First Author: Eloise Chapman-Davis

First Author: Alexandra Leary